Harkin Questions FDA In Wake Of J&J Drug Recall

Law360, New York (May 25, 2010, 2:00 PM EDT) -- Sen. Tom Harkin, D-Iowa, is asking whether regulators at the U.S. Food and Drug Administration have sufficient authority to prevent and respond to contamination in the U.S. drug supply, on the heels of the recall of 40 popular pediatric medicines made by a Johnson & Johnson unit.

In a letter sent Monday to FDA Commissioner Margaret Hamburg, Harkin posed a series of questions surrounding the recall, events leading up to and consumer complaints that forced Johnson & Johnson subsidiary McNeil Consumer Healthcare to pull 40 over-the-counter...
To view the full article, register now.